JP2007512260A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007512260A5 JP2007512260A5 JP2006540130A JP2006540130A JP2007512260A5 JP 2007512260 A5 JP2007512260 A5 JP 2007512260A5 JP 2006540130 A JP2006540130 A JP 2006540130A JP 2006540130 A JP2006540130 A JP 2006540130A JP 2007512260 A5 JP2007512260 A5 JP 2007512260A5
- Authority
- JP
- Japan
- Prior art keywords
- treatment
- type
- heart
- hypertension
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 206010019280 Heart failures Diseases 0.000 claims 1
- 206010020772 Hypertension Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
Claims (1)
- 請求項１４記載のＡ形または請求項１５記載のＢ形の、心臓血管疾患の処置のため、好ましくは高血圧および心不全の処置のための、医薬を製造するための使用。
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH20382003 | 2003-11-28 | ||
| PCT/CH2004/000688 WO2005051909A1 (de) | 2003-11-28 | 2004-11-15 | Verfahren zur herstellung von {n-[1-(s)-carbalkoxy-3-phenylpropyl]-s-alanyl-2s, 3ar, 7as-octahydroindol-2-carbonsäure}verbindungen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007512260A JP2007512260A (ja) | 2007-05-17 |
| JP2007512260A5 true JP2007512260A5 (ja) | 2007-12-06 |
Family
ID=34624414
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006540130A Withdrawn JP2007512260A (ja) | 2003-11-28 | 2004-11-15 | ｛Ｎ−［１−（Ｓ）−カルボアルコキシ−３−フェニルプロピル］−Ｓ−アラニル−２Ｓ，３ａＲ，７ａＳ−オクタヒドロインドール−２−カルボン酸｝化合物類の製造方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20070135513A1 (ja) |
| EP (1) | EP1689711A1 (ja) |
| JP (1) | JP2007512260A (ja) |
| WO (1) | WO2005051909A1 (ja) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008545006A (ja) * | 2005-07-05 | 2008-12-11 | シプラ・リミテッド | Ａｃｅ阻害剤の合成方法 |
| US7943655B2 (en) | 2006-04-05 | 2011-05-17 | Universitat Zurich | Polymorphic and pseudopolymorphic forms of trandolaprilat, pharmaceutical compositions and methods for production and use |
| CN102498098A (zh) | 2009-07-16 | 2012-06-13 | 艾博特公司 | 作为群多普利中间体的(2S，3aR，7aS)-八氢-1H-吲哚羧酸的合成方法 |
| EP3489215B1 (en) * | 2016-07-21 | 2023-12-20 | Kaneka Corporation | Process for producing organic compound |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ202903A (en) * | 1981-12-29 | 1988-01-08 | Hoechst Ag | 1-- pe pyrrol-2-yl-carboxylic acid derivatives and pharmaceutical compositions |
| JPS6248696A (ja) * | 1985-08-27 | 1987-03-03 | Kanegafuchi Chem Ind Co Ltd | Ｎ−〔１（ｓ）−エトキシカルボニル−３−フエニルプロピル〕−ｌ−アラニル−ｌ−プロリンの製造法 |
| US6541635B1 (en) * | 2002-03-29 | 2003-04-01 | Everlight Usa, Inc. | Method for producing angiotensin converting enzyme inhibitor |
-
2004
- 2004-11-15 WO PCT/CH2004/000688 patent/WO2005051909A1/de active Application Filing
- 2004-11-15 JP JP2006540130A patent/JP2007512260A/ja not_active Withdrawn
- 2004-11-15 EP EP04797245A patent/EP1689711A1/de not_active Withdrawn
- 2004-11-15 US US10/580,638 patent/US20070135513A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007520565A5 (ja) | ||
| NO2018029I2 (no) | Kombinasjonen alogliptin og metformin, hver eventuelt i form av et farmasøytisk akseptabelt salt derav | |
| JP2004210767A5 (ja) | ||
| NO2017047I1 (no) | Tofacitinib, evt. i form av et farmasøytisk akseptabelt salt, inkludert citratsalt | |
| JP2003503454A5 (ja) | ||
| ATE469131T1 (de) | Sulfonamidderivate, ihre herstellung und ihre therapeutische anwendung | |
| JP2007514005A5 (ja) | ||
| USD618889S1 (en) | Post surgery shower bootie | |
| DK1562603T3 (da) | Nye l gemidler til behandling af kronisk obstruktive lungesydomme | |
| NO20035496D0 (no) | Substituerte sulfonamidforbindelser, fremgangsmåte for deres anvendelse sommedikament til behandling av CNS-forstyrrelser, overvekt og typeII-diabetes | |
| JP2007523178A5 (ja) | ||
| JP2007523135A5 (ja) | ||
| JP2006511520A5 (ja) | ||
| NO20062663L (no) | Nukleinsyre som spesifikt binder bioaktivt ghrelin | |
| ATE516285T1 (de) | Dihydropyridinonderivate | |
| EP2433634A3 (en) | Compounds, compositions and methods of inhibiting a-synuclein toxicity | |
| USD550069S1 (en) | Three-way bed risers | |
| DK1753725T3 (da) | Tetra-hydro-iso-quinolinsulfonamidderivater, fremstilling og terapeutisk anvendelse heraf. | |
| JP2008519810A5 (ja) | ||
| JP2003526626A5 (ja) | ||
| JP2008526936A5 (ja) | ||
| WO2005060949A3 (en) | Selective norepinephrine reuptake inhibitors for the treatment of hot flashes, impulse control disorders and personality change due to a general medical condition | |
| JP2009500486A5 (ja) | ||
| JP2007512260A5 (ja) | ||
| WO2007144699A3 (en) | Process for the preparation of alfuzosin |